DKK3 and neoplasm: DKK3 has not been described in meningioma, but was reportedly downregulated in malignant glioma and its expression had anti-tumor effects in glioblastoma in vivo and in vitro (increased expression blocks the WNT signaling pathway, decreased expression activates it) [21, 22].